Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Comarmond

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
La Revue De Medecine Interne|January 21, 2014
[Treatment of Behçet's disease]C Comarmond, B Wechsler, P Cacoub, et al.
La Revue De Medecine Interne|May 23, 2022
[Weakness and weight loss in a 62 year-old patient]P Legendre, P Couture, M Ponsoye, et al.
La Revue De Medecine Interne|July 10, 2022
[Cutaneous hyperpigmentation, flexion of interphalangeal joints and hallux valgus in a 42 year-old patient]C Comarmond, G Leroux, C Frances, et al.
Expert Opinion on Biological Therapy|May 16, 2017
Management of severe complications in Behçet's disease with TNF inhibitorsA C Desbois, H Vallet, F Domont, et al.
Rheumatology (Oxford, England)|March 8, 2021
Comment on: Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)C Comarmond, S Bensalha, A Lopes, et al.
Autoimmunity Reviews|February 18, 2016
Biotherapies in large vessel vasculitisY Ferfar, T Mirault, A C Desbois, et al.
La Revue De Medecine Interne|July 7, 2023
W Bigot, L Forzy, K Nassarmadji, et al.
Journal of Autoimmunity|August 1, 2018
mTOR pathway activation in large vessel vasculitisA Maciejewski-Duval, C Comarmond, A Leroyer, et al.
Infectious Diseases Now|July 1, 2021
Tocilizumab and COVID-19: Timing of administration assessmentQ Richier, V Jachiet, V Bonnemains, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Th1 and Th17 cytokines drive inflammation in Takayasu arteritisD Saadoun, M Garrido, C Comarmond, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
La Revue De Medecine Interne|January 21, 2014
[Treatment of Behçet's disease]C Comarmond, B Wechsler, P Cacoub, et al.
La Revue De Medecine Interne|May 23, 2022
[Weakness and weight loss in a 62 year-old patient]P Legendre, P Couture, M Ponsoye, et al.
La Revue De Medecine Interne|July 10, 2022
[Cutaneous hyperpigmentation, flexion of interphalangeal joints and hallux valgus in a 42 year-old patient]C Comarmond, G Leroux, C Frances, et al.
Expert Opinion on Biological Therapy|May 16, 2017
Management of severe complications in Behçet's disease with TNF inhibitorsA C Desbois, H Vallet, F Domont, et al.
Rheumatology (Oxford, England)|March 8, 2021
Comment on: Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)C Comarmond, S Bensalha, A Lopes, et al.
Autoimmunity Reviews|February 18, 2016
Biotherapies in large vessel vasculitisY Ferfar, T Mirault, A C Desbois, et al.
La Revue De Medecine Interne|July 7, 2023
W Bigot, L Forzy, K Nassarmadji, et al.
Journal of Autoimmunity|August 1, 2018
mTOR pathway activation in large vessel vasculitisA Maciejewski-Duval, C Comarmond, A Leroyer, et al.
Infectious Diseases Now|July 1, 2021
Tocilizumab and COVID-19: Timing of administration assessmentQ Richier, V Jachiet, V Bonnemains, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Th1 and Th17 cytokines drive inflammation in Takayasu arteritisD Saadoun, M Garrido, C Comarmond, et al.
Pageof 2